BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1365988)

  • 1. [Abnormalities in the immune system of MS patients and possibilities of immunological treatment].
    Salonen R; Ilonen J
    Duodecim; 1992; 108(1):82-92. PubMed ID: 1365988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of multiple sclerosis--2. Application of a new immunological basic research is close].
    Svenningsson A; Andersson M; Olsson T
    Lakartidningen; 1998 Dec; 95(49):5631-5. PubMed ID: 9863301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunological basis for treatment of multiple sclerosis.
    Holmøy T; Vartdal F
    Scand J Immunol; 2007 Oct; 66(4):374-82. PubMed ID: 17850581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific therapies in multiple sclerosis.
    Sospedra M; Martin R
    Int Rev Immunol; 2005; 24(5-6):393-413. PubMed ID: 16318988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nervous system diseases with immunologic disorders--present status of immunotherapy].
    Ono R; Hamaguchi K
    Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):122-6. PubMed ID: 7681462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: MHC associations and therapeutic implications.
    Holmes S; Friese MA; Siebold C; Jones EY; Bell J; Fugger L
    Expert Rev Mol Med; 2005 Feb; 7(3):1-17. PubMed ID: 15710050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-based therapy of multiple sclerosis.
    Kaufman MD
    N C Med J; 1995 Aug; 56(8):379-84. PubMed ID: 7566191
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
    Warabi Y; Yagi K; Hayashi H; Matsumoto Y
    J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B; Nessler S; Zhou D; Kieseier B; Hartung HP
    Nat Clin Pract Neurol; 2006 Apr; 2(4):201-11. PubMed ID: 16932551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of autoimmunity in multiple sclerosis].
    Chabas D; Liblau R
    Pathol Biol (Paris); 2000 Feb; 48(1):25-46. PubMed ID: 10729910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P; Garren H; Steinman L
    Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological aspects of multiple sclerosis].
    Bakouche P
    Munch Med Wochenschr; 1969 Sep; 111(39):1985-7. PubMed ID: 4309930
    [No Abstract]   [Full Text] [Related]  

  • 18. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapeutics of multiple sclerosis.
    Durelli L
    Acta Neurol (Napoli); 1991 Oct; 13(5):467-75. PubMed ID: 1723242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1984 Sep; 114(35):1186-90. PubMed ID: 6091263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.